A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 31/70 (2006.01) A61K 38/17 (2006.01) A61P 27/02 (2006.01) C07K 16/28 (2006.01)
Patent
CA 2357873
The present invention relates to methods of treating retinopathy, retinal ischemia and/or retinal edema comprising administering an integrin or integrin subunit antagonist, leukocyte adhesion-inducing cytokine antagonist or growth factor antagonist, a selectin antagonist or adhesion molecule antagonist.
La présente invention porte sur des procédés visant à traiter la rétinopathie, l'ischémie rétinienne et/ou l'oedème rétinien et consistant à administrer une intégrine ou un antagoniste d'une sous-unité d'intégrine, un antagoniste de cytokine induisant l'adhésion leucocytaire ou un antagoniste du facteur de croissance, un antagoniste de la sélectine ou un antagoniste de molécule d'adhésion.
Children's Medical Center Corporation
Norton Rose Or S.e.n.c.r.l.,s.r.l./llp
LandOfFree
The prevention and treatment of retinal ischemia and edema does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with The prevention and treatment of retinal ischemia and edema, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The prevention and treatment of retinal ischemia and edema will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1985525